Written by The Biosurgery Market is gaining momentum as the global healthcare sector focuses on improving surgical outcomes and reducing procedure-related complications. Increasing surgical volumes, aging populations, and the growing prevalence of chronic conditions are supporting demand for hemostatic agents, surgical sealants, bone-graft substitutes, and adhesion barriers.
Minimally invasive and robotic-assisted surgery are important growth drivers because these procedures can create greater demand for products that provide precise bleeding control and tissue sealing in confined surgical spaces. The market is also moving toward synthetic and recombinant materials that can offer consistent manufacturing and reduce concerns associated with some animal-derived biological products.
Bone-graft substitutes generated approximately USD 2.6 billion in revenue in 2025, driven by orthopedic trauma and spinal-fusion demand. General surgery remained the largest application, while cosmetic and reconstructive applications are projected to grow at a 7.9% CAGR as biomaterial-based tissue augmentation expands.
North America accounted for about 40% of the market in 2025, followed by Europe with roughly 28%. Asia-Pacific is forecast to achieve an 8.5% CAGR, supported by hospital expansion in China, India, and Southeast Asia. Future opportunities are expected from robotic-surgery integration, regenerative medicine, and value-based procurement.
Uncover future growth patterns with expert-driven reports:
Smart Contact Lenses Market Outlook
Weight Management Market Analysis